These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1136 related items for PubMed ID: 1915702

  • 1. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD, Bates LJ, Zhu SW, Castleberry RP, Gualtieri RJ, Zuckerman KS.
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [Abstract] [Full Text] [Related]

  • 2. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia.
    Gualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML.
    Blood; 1989 Nov 15; 74(7):2360-7. PubMed ID: 2679915
    [Abstract] [Full Text] [Related]

  • 3. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
    Freedman MH, Hitzler JK, Bunin N, Grunberger T, Squire J.
    Stem Cells; 1996 Nov 15; 14(6):690-701. PubMed ID: 8948026
    [Abstract] [Full Text] [Related]

  • 4. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb 15; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 5. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD, Stackpoole A, Meager A, Tikerpae J.
    J Immunol; 1992 Oct 15; 149(8):2681-8. PubMed ID: 1383322
    [Abstract] [Full Text] [Related]

  • 6. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
    Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, Aglietta M.
    Cancer Res; 1990 Aug 15; 50(16):5065-71. PubMed ID: 1696165
    [Abstract] [Full Text] [Related]

  • 7. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
    Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z.
    Br J Haematol; 1992 Jan 15; 80(1):40-8. PubMed ID: 1311195
    [Abstract] [Full Text] [Related]

  • 8. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec 15; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 9. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T, Sekhavat M, Rubinstein DB, Hamdan O, Symann ML.
    Cancer Res; 1993 Jul 01; 53(13):3139-44. PubMed ID: 8319222
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D, Goldschmitt J, Aulitzky WE, Huber C, Peschel C.
    Exp Hematol; 1995 Dec 01; 23(14):1431-8. PubMed ID: 8542928
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec 01; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 12. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE, Lu L, Cooper S, Tushinski R, Mochizuki D, Rubin BY, Gillis S, Williams DE.
    J Immunol; 1988 Dec 01; 141(11):3852-62. PubMed ID: 3053902
    [Abstract] [Full Text] [Related]

  • 13. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
    Brach MA, Gruss HJ, Asano Y, de Vos S, Ludwig WD, Mertelsmann R, Herrmann F.
    Cancer Res; 1992 Apr 15; 52(8):2197-201. PubMed ID: 1373106
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW, Li F, Pettit GR, Grant S.
    Exp Hematol; 1993 Jul 15; 21(7):893-900. PubMed ID: 7686503
    [Abstract] [Full Text] [Related]

  • 15. Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor.
    Alsalameh S, Firestein GS, Oez S, Kurrle R, Kalden JR, Burmester GR.
    J Rheumatol; 1994 Jun 15; 21(6):993-1002. PubMed ID: 7932447
    [Abstract] [Full Text] [Related]

  • 16. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R.
    J Cell Physiol; 1996 Mar 15; 166(3):618-30. PubMed ID: 8600166
    [Abstract] [Full Text] [Related]

  • 17. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
    Estrov Z, Markowitz AB, Kurzrock R, Wetzler M, Kantarjian HM, Ferrajoli A, Gutterman JU, Talpaz M.
    Leukemia; 1993 Feb 15; 7(2):214-20. PubMed ID: 8426475
    [Abstract] [Full Text] [Related]

  • 18. Production of hematopoietic regulatory cytokines by peripheral blood mononuclear cells in patients with aplastic anemia.
    Hsu HC, Tsai WH, Chen LY, Hsu ML, Ing-Tiau Kuo B, Ho CH, Lin CK, Wang SY.
    Exp Hematol; 1996 Jan 15; 24(1):31-6. PubMed ID: 8536789
    [Abstract] [Full Text] [Related]

  • 19. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R, van Buitenen C, Salem M, Oosterom R, Touw I, Löwenberg B.
    Leukemia; 1990 Aug 15; 4(8):557-60. PubMed ID: 2201834
    [Abstract] [Full Text] [Related]

  • 20. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep 15; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.